182963-94-6 Usage
Description
3-[3-(Dimethylamino)propoxy]benzylamine, also known as 3-(Dimethylamino)propoxybenzylamine, is a chemical compound belonging to the benzylamines class, characterized by an amine group attached to a benzyl group. With the molecular formula C13H21NO, this tertiary amine features a benzyl group connected to a 3-(dimethylamino)propoxy group, indicating its potential for various applications in chemical synthesis and medicinal chemistry.
Uses
Used in Chemical Synthesis:
3-[3-(Dimethylamino)propoxy]benzylamine is used as a reagent in chemical reactions for its ability to facilitate the formation of new compounds through its amine and propoxy functionalities.
Used in Pharmaceutical Production:
As an intermediate, 3-[3-(Dimethylamino)propoxy]benzylamine is utilized in the production of various pharmaceuticals, contributing to the synthesis of active ingredients in medications.
Used in Medicinal Chemistry Research:
3-[3-(Dimethylamino)propoxy]benzylamine is of interest in the field of medicinal chemistry due to its potential pharmacological properties, which may include a range of biological activities that are under investigation for therapeutic applications.
Different applications in various industries may include its use in the development of new organic compounds for specific industrial processes or as a component in the formulation of specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 182963-94-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,2,9,6 and 3 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 182963-94:
(8*1)+(7*8)+(6*2)+(5*9)+(4*6)+(3*3)+(2*9)+(1*4)=176
176 % 10 = 6
So 182963-94-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H20N2O/c1-14(2)7-4-8-15-12-6-3-5-11(9-12)10-13/h3,5-6,9H,4,7-8,10,13H2,1-2H3
182963-94-6Relevant articles and documents
Imidazoquinazoline derivatives
-
, (2008/06/13)
The present invention relates to imidazoquinazoline derivatives represented by formula (I): STR1 wherein R1 represents hydrogen, substituted or unsubstituted lower alkyl, cycloalkyl, lower alkenyl, substituted or unsubstituted aralkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroarylalkyl, or substituted or unsubstituted heteroaryl, R2 and R3 represent independently hydrogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroarylalkyl, or substituted or unsubstituted heteroaryl, or R2 and R3 are combined to represent a heterocyclic group containing a nitrogen atom, R4 represents hydrogen or substituted or unsubstituted lower alkyl, X represents O or S, Y represents a single bond or O, n represents 0, 1, 2, or 3, and pharmaceutically acceptable salts thereof.
